Sun Pharmaceutical Industries Limited(IN:SUNPHARMA)
₹1,880.90-5.90 (-0.31%)
IN:SUNPHARMA
Sun Pharmaceutical Industries Limited financials statements
₹1,880.90
At close:-5.90 (-0.31%)
Want to see IN:SUNPHARMA full AI Analyst Report?
Sun Pharmaceutical Industries Limited (SUNPHARMA) Income Statement
24 Followers
Sun Pharmaceutical Industries Limited Income Statement
Last quarter (Q2 2027), Sun Pharmaceutical Industries Limited's total revenue was ₹161.99B, an increase of 11.88% from the same quarter last year. In Q2, Sun Pharmaceutical Industries Limited's net income was ₹19.89B. See Sun Pharmaceutical Industries Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 584.62B | ₹ 525.78B | ₹ 484.97B | ₹ 438.86B | ₹ 386.54B | |
| ₹ 325.62B | ₹ 410.20B | ₹ 370.55B | ₹ 325.67B | ₹ 277.78B | |
| ₹ 190.08B | ₹ 132.05B | ₹ 126.30B | ₹ 106.63B | ₹ 94.87B | |
| Depreciation and Amortization | ₹ 29.38B | ₹ 25.75B | ₹ 25.57B | ₹ 25.30B | ₹ 21.44B |
| ₹ 183.40B | ₹ 151.81B | ₹ 130.77B | ₹ 118.36B | ₹ 103.00B | |
| ₹ 135.53B | ₹ 278.15B | ₹ 244.24B | ₹ 219.04B | ₹ 182.91B | |
| ₹ 15.10B | ₹ -140.78B | ₹ -133.75B | ₹ -125.44B | ₹ -138.27B | |
| ₹ 150.63B | ₹ 137.37B | ₹ 110.49B | ₹ 93.61B | ₹ 44.65B | |
| ₹ 114.79B | ₹ 109.29B | ₹ 95.76B | ₹ 84.74B | ₹ 32.73B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 47.80 | ₹ 45.60 | ₹ 39.91 | ₹ 35.32 | ₹ 13.64 |
| Diluted EPS | ₹ 47.80 | ₹ 45.60 | ₹ 39.91 | ₹ 35.32 | ₹ 13.64 |
| Weighted Average Shares Outstanding | 2.40B | 2.40B | 2.40B | 2.40B | 2.40B |
| Weighted Average Shares Outstanding (Diluted) | 2.40B | 2.40B | 2.40B | 2.40B | 2.40B |
Currency in INR
